Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

Blood Cancer Journal, Published online: 19 February 2024; doi:10.1038/s41408-024-00990-3Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

Source: Blood Cancer Journal - February 19, 2024 Category: Hematology Authors: Eolia Brissot Myriam Labopin Helene Labussi ère Gaelle Fossard Patrice Chevallier Thierry Guillaume Ibrahim Yakoub-Agha Micha Srour Claude-Eric Bulabois Anne Huynh Sylvain Chantepie Anne-Lise Menard Marie-Therese Rubio Patrice Ceballos R émy Dulery Sabi Source Type: research